Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00302198 · ClinicalTrials.gov registry record
Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org
A clinical trial of Amyotrophic Lateral Sclerosis, sponsored by Forbes Norris MDA/ALS Research Center.
- Completed
- Registry status
- 15,000
- Enrollment target
- 1
- Study location
NCT00302198: Completed study of Amyotrophic Lateral Sclerosis, sponsored by Forbes Norris MDA/ALS Research Center.
NCT00302198 is a study of Amyotrophic Lateral Sclerosis that has completed, run by Forbes Norris MDA/ALS Research Center. The registered enrollment target is 15,000 participants, above the 751-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (1897% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00302198, a study of Amyotrophic Lateral Sclerosis, has completed, sponsored by Forbes Norris MDA/ALS Research Center.
- COMPLETED
- Registry status
- 15,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose is to collect data for ALS research. The data will be used to learn more about the origin of ALS and to improve quality of care for people with ALS. The information you provide in the ALS registry will be used to evaluate variations in patient care, adherence to standards of care and also to help foster ALS research.
Conditions Studied
Interventions
- BEHAVIORAL ALS Registry
Study Locations (1)
California
- Forbes Norris MDA/ALS Center - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,000 participants |
| Start Date | 2006-01 |
| Est. Completion | 2010-02 |
What the finished NCT00302198 record still lists
NCT00302198 is an observational study that tracks outcomes without assigning an intervention. Its 15,000 participants enrollment target places it among the larger protocols in the corpus, above the 751-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (1897% higher).
The record links to 1 condition, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which ALS Registry is the first listed.
NCT00302198 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00302198 about?
NCT00302198 is a clinical study titled "Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org". The purpose is to collect data for ALS research. The data will be used to learn more about the origin of ALS and to improve quality of care for people with ALS. The information you provide in the ALS registry will be used to evaluate variations in patient care, adherence to standards of care and als...
What is the current status of trial NCT00302198?
This trial is currently completed. The enrollment target is 15,000 participants. The study started on 2006-01. Estimated completion is 2010-02.
What conditions does trial NCT00302198 study?
This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis.
What interventions are being tested in trial NCT00302198?
The interventions under investigation include: ALS Registry (BEHAVIORAL).
Who is sponsoring clinical trial NCT00302198?
This trial is sponsored by Forbes Norris MDA/ALS Research Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00302198 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyotrophic Lateral Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00302198's enrollment target sits among peer trials
15,000 2nd of 102 the highest of 102 other Amyotrophic Lateral Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amyotrophic Lateral Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Assessing Perceptual Effects of Interactive Tasks
RECRUITING · NA
-
PREVENT ALL ALS Study
RECRUITING
-
Spinal Cord Associative Plasticity for ALS
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
- NCT01137643 · 15,000 participants
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- NCT01550575 · 15,000 participants
Patient Retrospective Outcomes (PRO)
- NCT02253251 · 15,000 participants
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia